Interaction of vaccinia virus complement control protein with human complement proteins: Factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway

Journal of Immunology

Volumn 160, Issue 11, 1998, Pages 5596-5604

  Sahu, Arvind ^a   Isaacs, Stuart N ^b   Soulika, Athena M ^a   Lambris, John D ^a,b  

^a Laboratory Medicine   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C3D; COMPLEMENT COMPONENT C4; COMPLEMENT FACTOR H; COMPLEMENT FACTOR I; ELASTASE; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIRUS COMPLEMENT CONTROL PROTEIN;

ARTICLE; COMPLEMENT ALTERNATIVE PATHWAY; CONTROLLED STUDY; HOST RESISTANCE; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; VACCINIA VIRUS; VIRUS INFECTION; VIRUS RESISTANCE; VIRUS VIRULENCE; YEAST CELL;

ARGININE; BINDING SITES; COMPLEMENT C3-C5 CONVERTASES; COMPLEMENT C3B; COMPLEMENT C3B INACTIVATOR PROTEINS; COMPLEMENT C3C; COMPLEMENT C3D; COMPLEMENT FACTOR H; COMPLEMENT PATHWAY, ALTERNATIVE; FIBRINOGEN; HUMANS; HYDROLYSIS; RECEPTORS, COMPLEMENT; RECEPTORS, COMPLEMENT 3B; RECOMBINANT PROTEINS; SERINE; VACCINIA VIRUS; VIRAL PROTEINS;

EID: 0032104032     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Gooding, L. R. 1992. Virus proteins that counteract host immune defenses. Cell 71:5.
2. Hall, B. F., and K. A. Joiner. 1991. Strategies of obligate intracellular parasites for evading host defences. Immunol. Today 12:A22.
3. Welsh, R. M. J., N. R. Cooper, F. C. Jensen, and M. B. Oldstone. 1975. Human serum lyses RNA tumour viruses. Nature 257:612.
4. Lambris, J. D., A. Sahu, and R. Wetsel. 1998. Chemistry and Biology of C3, C4, and C5. In The Human Complement System in Health ana Disease. J. E. Volanakis and M. Frank, ed. Marcel Dekker, Inc., New York, pp. 83-118.
5. McNearney, T. A., C. Odell, V. M. Holers, P. G. Spear, and J. P. Atkinson. 1987. Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivity. J. Exp. Med. 166:1525.
6. Kostavasil, I., A. Sahu, H. M. Friedman, R. J. Eisenberg, G. H. Cohen, and J. D. Lambris. 1997. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus. J. Immunol. 158:1763.
7. Smith, G. L. 1994. Virus strategies for evasion of the host response to infection. Trends Microbiol. 2:81.
8. Sahu, A., J. O. Sunyer, W. T. Moore, M. R. Sarrias, A. M. Soulika, and J. D. Lambris. 1998. Structure, function, and evolution of the third complement component and viral molecular mimicry. Immunol. Res. 17:109.
9. Cooper, N. R. 1991. Complement evasion strategies of microorganisms. Immunol. Today 12:327.
10. Kotwal, G. J., and B. Moss. 1988. Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins. Nature 335:176.
11. Kotwal, G. J., S. N. Isaacs, R. Mckenzie, M. M. Frank, and B. Moss. 1990. Inhibition of the complement cascade by the major secretory protein of vaccinia virus. Science 250:827.
12. Isaacs, S. N., G. J. Kotwal, and B. Moss. 1992. Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence. Proc. Natl. Acad. Sci. USA 89:628.
13. Mckenzie, R., G. J. Kotwal, B. Moss, C. H. Hammer, and M. M. Frank. 1992. Regulation of complement activity by vaccinia virus complement-control protein. J. Infect. Dis. 166:1245.
14. Hammer, C. H., G. H. Wirtz, L. Renfer, H. D. Gresham, and B. F. Tack. 1981. Large scale isolation of functionally active components of the human complement system. J. Biol. Chem. 256:3995.
15. Lambris, J. D., and H. J. Muller-Eberhard. 1984. Isolation and characterization of a 33,000-dalton fragment of complement factor B with catalytic and C3b binding activity. J. Biol. Chem. 259:12685.
16. Alsenz, J., T. F. Schulz, J. D. Lambris, R. B. Sim, and M. P. Dierich. 1985. Structural and functional analysis of the complement component factor H with the use of different enzymes and monoclonal antibodies to factor H. Biochem. J. 232:841.
17. Hsiung, L.-M., A. N. Barclay, M. R. Brandon, E. Sim, and R. R. Porter. 1982. Purification of human C3b inactivator by monoclonal-antibody affinity chromatography. Biochem. J. 203:293.
18. Pangburn, M. K. 1987. A fluorimetric assay for native C3: the hemolytically active form of the third component of human complement. J. Immunol. Methods 102:7.
19. Becherer, J. D., and J. D. Lambris. 1988. Identification of the C3b receptor-binding domain in third component of complement. J. Biol. Chem. 263:14586.
20. Hessing, M., J. Paardekooper, and C. E. Hack. 1993. Separation of different forms of the fourth component of human complement by fast protein liquid chromatography. J. Immunol. Methods 157:39.
21. Rux, A. H., W. T. Moore, J. D. Lambris, W. R. Abrams, C. Peng, H. M. Friedman, G. H. Cohen, and R. J. Eisenberg. 1996. Disulfide bond structure determination and biochemical analysis of glycoprotein C from herpes simplex virus. J. Virol. 70:5455.
22. Sahu, A., and M. K. Pangburn. 1996. Investigation of mechanism-based inhibitors of complement targeting the activated thioester of human C3. Biochem. Pharmacol. 51:797.
23. von Zabern, I., E. L. Bloom, V. Chu, and I. Gigli. 1982. The fourth component of human complement treated with amines or chaotropes or frozen-thawed (C4b-like C4): interaction with C4 binding protein and cleavage by C3b/C4b inactivator. J. Immunol. 128:1433.
24. Miller, C. G., S. N. Shchelkunov, and G. J. Kotwal. 1997. The cowpox virus-encoded homolog of the vaccinia virus complement control protein is an inflammation modulatory protein. Virology 229:126.
25. Sharma, A. K., and M. K. Pangburn. 1994. Biologically active recombinant human complement factor H: synthesis and secretion by the baculovirus system. Gene 143:301.
26. Weisman, H. F., T. Bartow, M. K. Leppo, H. C. J. Marsh, G. R. Carson, M. F. Concino, M. P. Boyle, K. H. Roux, O. L. Weisfeldt, and D. T. Fearon. 1990. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 249:146.
27. Kuhn, S., and P. F. Zipfel. 1995. The baculovirus expression vector pBSV-8His directs secretion of histidine-tagged proteins. Gene 162:225.
28. Gordon, D. L., R. M. Kaufman, T. K. Blackmore, J. Kwong, and D. M. Lublin. 1995. Identification of complement regulatory domains in human factor H. J. Immunol. 155:348.
29. Subramanian, V. B., L. Clemenza, M. Krych, and J. P. Atkinson. 1996. Substitution of two amino acids confers C3b binding to the C4b binding site of CR1 (CD35): analysis based on ligand binding by chimpanzee erythrocyte complement receptor. J. Immunol. 157:1242.
30. Meri, S., and M. K. Pangburn. 1990. Discrimination between activators and non-activators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H. Proc. Natl. Acad. Sci. USA 87:3982.
31. Kazatchkine, M. D., D. T. Fearon, and K. F. Austen. 1979. Human alternative complement pathway: membrane-associated sialic acid regulates the competition between B and β1H for cell-bound C3b. J. Immunol. 122:75.
32. Goebel, S. J., G. P. Johnson, M. E. Perkus, S. W. Davis, J. P. Winslow, and E. Paoletti. 1990. The complete DNA sequence of vaccinia virus. Virology 179:247.
33. Takahashi-Nishimaki, F., S. Funahashi, K. Miki, S. Hashizume, and M. Sugimoto. 1991. Regulation of plaque size and host range by a vaccinia virus gene related to complement control proteins. Virology 181:158.
34. Engelstad, M., S. T. Howard, and G. L. Smith. 1992. A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope. Virology 188:801.
35. Isaacs, S. N., E. J. Wolffe, L. G. Payne, and B. Moss. 1992. Characterization of a vaccinia virus-encoded 42-kilodalton class 1 membrane glycoprotein component of the extracellular virus envelope. J. Virol. 66:7217.
36. Martinez-Pomares, L., R. J. Stern, and R. W. Moyer. 1993. The ps/hr gene (B5R open reading frame homolog) of rabbitpox virus controls pock color, is a component of the extracellular enveloped virus, and is secreted into the medium. J. Virol. 67:5440.
37. Rosengard, A. M., L. A. Turka, L. C. Korb, W. M. Baldwin III, F. Sanfilippo, and J. M. Ahearn. 1996. Functional comparison of vaccinia virus complement-control protein and human CR1. Mol. Immunol. 33:265 (Abstr.).
38. Klickstein, L. B., T. J. Bartow, V. Miletic, L. D. Rabson, J. A. Smith, and D. T. Fearon. 1988. Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CRI, CD35) by deletion mutagenesis. J. Exp. Med. 168:1699.
39. Krych, M., D. Hourcade, and J. P. Atkinson. 1991. Sites within the complement C3b C4b receptor important for the specificity of ligand binding. Proc. Natl. Acad. Sci. USA 88:4353.
40. Alsenz, J., J. D. Lambris, T. F. Schulz, and M. P. Dierich. 1984. Localization of the complement-component-C3b-binding site and the cofactor activity for factor I in the 38kDa tryptic fragment of factor H. Biochem. J. 224:389.
41. Sharma, A. K., and M. K. Pangburn. 1996. Identification of three physically and functionally distinct binding sites for C3b in human complement factor H by deletion mutagenesis. Proc. Natl. Acad. Sci. USA 93:10996.